Should You Buy ServiceNow Stock Instead of UiPath Stock? | NOW Stock Analysis | PATH Stock Analysis
2 extracted signals · 0 resolved · 2 still active
Parkev Tatevosian, CFA06 Jul 2026, 11:45 UTC
AI-generated source summary
The analysis compares UiPath (PATH) and ServiceNow (NOW) based on financial metrics and market sentiment. Both stocks have experienced significant price declines, with PATH down approximately 29% and NOW down 31% by July 2026. Revenue growth for ServiceNow is strong, projected at $14 billion by 2026, compared to PATH's $1.67 billion. ServiceNow's operating margin has also improved dramatically, from -60% in 2020 to 14.76% currently, while PATH's is at 6.28%. On a return on invested capital basis, ServiceNow (12.71%) is lower than PATH (16.91%), but both show improving trends. Valuation-wise, both are trading at historically low forward P/E ratios: NOW at 25.67 and PATH at 14.86. The analysis suggests both companies are undervalued based on their intrinsic cash flow value, with PATH appearing cheaper. The speaker favors ServiceNow for its stronger growth and improving profitability, despite its higher valuation, and rates both as buys.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
2 signals remain active.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.